Archean Chemical Q1 FY27: Bromine Strength, Salt Logistics Headwinds, and Big Bets in Semicon

Consolidated total income was Rs. 3,328 million (Rs. 332.8 crore), EBITDA was Rs. 728.7 million (Rs. 72.9 crore), and PAT was Rs. 304 million (Rs. 30.4 crore).

Bromine revenue was Rs. 1,333 million (Rs. 133.3 crore), up 58% YoY, with volumes of 4,175 tons. Management indicated realizations were near INR 300 per kg and expected to remain broadly firm, acknowledging volatility.

Industrial Salt revenue fell to Rs. 1,713 million (Rs. 171.3 crore) and volumes declined to 0.98 million tons due to logistics and transportation challenges, vessel shortages, higher freight costs, and conflict-related order deferments.

Acume revenue increased to about Rs. 298 million (Rs. 29.8 crore) and the business turned EBITDA positive at Rs. 19 million (Rs. 1.9 crore) due to improved product mix (higher organic derivatives), cost control, and pricing discipline.

SOP revenue reached Rs. 113 million (Rs. 11.3 crore) in Q1 FY27. Management stated Phase 1 trials were completed in June 2026 and Phase 2 trials are planned by end of Q3 FY27/December 2026, with meaningful contribution expected in H2 FY27.

Management indicated a 24-27 month execution timeline after the FSA signed on May 11, 2026. Total capex was cited at USD 249 million, with 15-20% already incurred, 60-65% expected in FY27, and the remainder in FY28.

Offgrid inaugurated a 10 MWh zinc bromide battery pilot manufacturing line in Hook, UK. Management described three horizons: stabilizing the pilot, scaling zinc bromide chemical supply, and later evaluating larger-scale deployments in India.